Genmab — Juli 2018
-
Så er DVMp på Chmp's dagsorden. Side 23. Mon så ikke der kommer en udtalelse på fredag. http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2018/07/WC500252374.pdf
-
Tak Bulder, så er der håb denne gang
-
-
this is the Public summary pdf on the granting of orphan designation for Dara for the treatment of AL amyloidosis we saw a few weeks ago, not sure if we posted it yet http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2018/07/WC500252417.pdf
-
Expert Highlights Current and Emerging Immunotherapy Treatment Options in Multiple Myeloma https://www.targetedonc.com/news/expert-highlights-current-and-emerging-immunotherapy-treatment-options-in-multiple-myeloma
-
God morgen
-
this shows that the JNJ-63723283 - Dara study that was halted had only enrolled 10 patients https://clinicaltrials.gov/ct2/history/NCT03357952?A=7&B=8&C=merged
-
the (D-RVd) vs (RVd) is now set to an actual recruitment of 224 https://clinicaltrials.gov/ct2/history/NCT02874742?A=24&B=25&C=merged
-
this atezolizumab for MM trial was also updated https://clinicaltrials.gov/ct2/history/NCT02431208?A=39&B=40&C=merged
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind